Has Pamela Mason, MD received payments from drug or device companies?

Yes. Drug and device makers reported $130,446 in general payments to Pamela Mason, MD across 304 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pamela Mason, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pamela Mason, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pamela Mason, MD

Clinical Cardiac Electrophysiology · Charlottesville, VANPI 1154310605

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.7% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $40,694, more than ten times the $2,987 reported in 2019. Among clinical cardiac electrophysiology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,446in general payments, 2019–2025

Across 304 payments — averaging $429.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$97K
Abbott$13K
Boston Scientific$13K
Cook Incorporated$5K
Cook Medical LLC$2K
Medical Device Business Services, Inc.$595
plus $255 from 1 others

$774,531in research payments, 2019–2025

Across 144 payments — averaging $5378.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$728K
Cook Research Incorporated$30K
Boston Scientific$17K

What the payments were for

Consulting fees$17,07513%
Speaking & faculty fees$67,30552%
Travel & lodging$33,47426%
Food & beverage$12,52310%
Education$690%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	208	$97,496
Abbott	66	$12,889
Boston Scientific	14	$12,740
Cook Incorporated	2	$4,880
Cook Medical LLC	10	$1,591
Medical Device Business Services, Inc.	1	$595
Philips North America LLC	3	$255

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$16,949
GENERAL - THERAPIES$11,188
Evolution$5,098
ENSITE PRECISION$4,946
AVEIR$3,704
AURORA EV-ICD MRI SURESCAN$1,713
TACTICATH ABLATION CATHETER, SENSOR ENABLED$1,351
AMPLATZER AMULET$1,165
Cook Medical Lead Management - Lead Extraction$1,128
CLINICAL TRIAL PRODUCT$938
Carto 3$595
Arctic Front$481
(9520) IGT Devices Undivided$174
JOT DX$154
TYRX$150
Farapulse$107
AFFERA MAPPING SYSTEM$104
LINQ II$101

How this compares

$130,446 in reported general payments places this provider in the 90th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia →

Medicare billing

Part B allowed, 2024

$209,803

Medicare patients

1,162

Services billed

3,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	258	$335,545
XareltoRivaroxaban	50	$42,239
Dofetilide	27	$9,410
Flecainide Acetate	88	$3,795
Propafenone Hcl ErPropafenone Hcl	14	$3,266
Metoprolol Succinate	210	$2,738
Nadolol	13	$1,176
Amiodarone Hcl	47	$934
Carvedilol	41	$563
Metoprolol Tartrate	35	$328
Diltiazem 24hr Er (Cd)Diltiazem Hcl	16	$243
Losartan Potassium	15	$162
Amlodipine Besylate	11	$153
Furosemide	15	$100
Hydrochlorothiazide	15	$85

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Charlottesville

Oliver MonfrediCharlottesville$231K
John MounseyCharlottesville$70K
James MangrumCharlottesville$46K
John DimarcoCharlottesville$23K
George ProusiCharlottesville$16K
John FergusonCharlottesville$9K
Kenneth EllenbogenRichmond$360K
Brett AtwaterFairfax$319K
Peem LorvidhayaFredericksburg$230K
Erich KiehlNewport News$181K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →